467 related articles for article (PubMed ID: 26439174)
1. Directed differentiation of definitive hemogenic endothelium and hematopoietic progenitors from human pluripotent stem cells.
Ditadi A; Sturgeon CM
Methods; 2016 May; 101():65-72. PubMed ID: 26439174
[TBL] [Abstract][Full Text] [Related]
2. Directed Differentiation of Primitive and Definitive Hematopoietic Progenitors from Human Pluripotent Stem Cells.
Dege C; Sturgeon CM
J Vis Exp; 2017 Nov; (129):. PubMed ID: 29155741
[TBL] [Abstract][Full Text] [Related]
3. Cytokine-free directed differentiation of human pluripotent stem cells efficiently produces hemogenic endothelium with lymphoid potential.
Galat Y; Dambaeva S; Elcheva I; Khanolkar A; Beaman K; Iannaccone PM; Galat V
Stem Cell Res Ther; 2017 Mar; 8(1):67. PubMed ID: 28302184
[TBL] [Abstract][Full Text] [Related]
4. CD1d expression demarcates CDX4+ hemogenic mesoderm with definitive hematopoietic potential.
Philip Creamer J; Luff SA; Yu H; Sturgeon CM
Stem Cell Res; 2022 Jul; 62():102808. PubMed ID: 35569347
[TBL] [Abstract][Full Text] [Related]
5. On signaling pathways: hematopoietic stem cell specification from hemogenic endothelium.
Long Y; Huang H
Sci China Life Sci; 2015 Dec; 58(12):1256-61. PubMed ID: 26612042
[TBL] [Abstract][Full Text] [Related]
6. The balance of positive and negative effects of TGF-β signaling regulates the development of hematopoietic and endothelial progenitors in human pluripotent stem cells.
Bai H; Xie YL; Gao YX; Cheng T; Wang ZZ
Stem Cells Dev; 2013 Oct; 22(20):2765-76. PubMed ID: 23758278
[TBL] [Abstract][Full Text] [Related]
7. Human pluripotent stem cells differentiated in fully defined medium generate hematopoietic CD34- and CD34+ progenitors with distinct characteristics.
Chicha L; Feki A; Boni A; Irion O; Hovatta O; Jaconi M
PLoS One; 2011 Feb; 6(2):e14733. PubMed ID: 21364915
[TBL] [Abstract][Full Text] [Related]
8. Wnt signaling controls the specification of definitive and primitive hematopoiesis from human pluripotent stem cells.
Sturgeon CM; Ditadi A; Awong G; Kennedy M; Keller G
Nat Biotechnol; 2014 Jun; 32(6):554-61. PubMed ID: 24837661
[TBL] [Abstract][Full Text] [Related]
9. Efficient and simultaneous generation of hematopoietic and vascular progenitors from human induced pluripotent stem cells.
Park TS; Zimmerlin L; Zambidis ET
Cytometry A; 2013 Jan; 83(1):114-26. PubMed ID: 22736485
[TBL] [Abstract][Full Text] [Related]
10. Early Human Hemogenic Endothelium Generates Primitive and Definitive Hematopoiesis In Vitro.
Garcia-Alegria E; Menegatti S; Fadlullah MZH; Menendez P; Lacaud G; Kouskoff V
Stem Cell Reports; 2018 Nov; 11(5):1061-1074. PubMed ID: 30449319
[TBL] [Abstract][Full Text] [Related]
11. NOTCH signaling specifies arterial-type definitive hemogenic endothelium from human pluripotent stem cells.
Uenishi GI; Jung HS; Kumar A; Park MA; Hadland BK; McLeod E; Raymond M; Moskvin O; Zimmerman CE; Theisen DJ; Swanson S; J Tamplin O; Zon LI; Thomson JA; Bernstein ID; Slukvin II
Nat Commun; 2018 May; 9(1):1828. PubMed ID: 29739946
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic Developmental Potential of Human Pluripotent Stem Cell Lines Is Accompanied by the Morphology of Embryoid Bodies and the Expression of Endodermal and Hematopoietic Markers.
Tesarova L; Simara P; Stejskal S; Koutna I
Cell Reprogram; 2017 Aug; 19(4):270-284. PubMed ID: 28632430
[TBL] [Abstract][Full Text] [Related]
13. ID1 and ID3 represent conserved negative regulators of human embryonic and induced pluripotent stem cell hematopoiesis.
Hong SH; Lee JH; Lee JB; Ji J; Bhatia M
J Cell Sci; 2011 May; 124(Pt 9):1445-52. PubMed ID: 21486943
[TBL] [Abstract][Full Text] [Related]
14.
Garcia-Alegria E; Potts B; Menegatti S; Kouskoff V
STAR Protoc; 2021 Mar; 2(1):100367. PubMed ID: 33718891
[TBL] [Abstract][Full Text] [Related]
15. Human definitive haemogenic endothelium and arterial vascular endothelium represent distinct lineages.
Ditadi A; Sturgeon CM; Tober J; Awong G; Kennedy M; Yzaguirre AD; Azzola L; Ng ES; Stanley EG; French DL; Cheng X; Gadue P; Speck NA; Elefanty AG; Keller G
Nat Cell Biol; 2015 May; 17(5):580-91. PubMed ID: 25915127
[TBL] [Abstract][Full Text] [Related]
16. Application of small molecule CHIR99021 leads to the loss of hemangioblast progenitor and increased hematopoiesis of human pluripotent stem cells.
Galat Y; Elcheva I; Dambaeva S; Katukurundage D; Beaman K; Iannaccone PM; Galat V
Exp Hematol; 2018 Sep; 65():38-48.e1. PubMed ID: 29879440
[TBL] [Abstract][Full Text] [Related]
17. Generation of Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells.
Oguro H
Methods Mol Biol; 2019; 2048():245-257. PubMed ID: 31396942
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Endothelial-to-Hematopoietic Transition of Individual Hemogenic Endothelium and Bulk Populations in Defined Conditions.
Uenishi GI; Jung HS; Slukvin II
Methods Mol Biol; 2022; 2429():103-124. PubMed ID: 35507158
[TBL] [Abstract][Full Text] [Related]
19. Activin A promotes hematopoietic fated mesoderm development through upregulation of brachyury in human embryonic stem cells.
Cerdan C; McIntyre BA; Mechael R; Levadoux-Martin M; Yang J; Lee JB; Bhatia M
Stem Cells Dev; 2012 Oct; 21(15):2866-77. PubMed ID: 22548442
[TBL] [Abstract][Full Text] [Related]
20. Protocol for the Generation of Definitive Hematopoietic Progenitors from Human Pluripotent Stem Cells.
Nafria M; Bonifer C; Stanley EG; Ng ES; Elefanty AG
STAR Protoc; 2020 Dec; 1(3):100130. PubMed ID: 33377024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
